ERBB2/3 has been shown to be overexpressed in breast, ovarian, bladder, stomach, and salivary carcinomas, thereby impairing normal cellular control mechanisms and giving rise to malignant tumor cell transformation [42]. The gene discussed is ERBB2; the disease is salivary gland carcinoma.